MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    The Effects of Baduanjin on Fine Motor Skills in Mild and Moderate Parkinson’s Disease

    JUN. Li, KF. Li, HZ. Chen, WM. Yang (Hefei, China)

    Objective: To investigate whether Baduanjin Qigong exercise could help improve fine motor skills in patients with Parkinson's disease. Background: It is common for people with…
  • 2024 International Congress

    Neuroprotective Action of Betulin in Parkinson’s disease: Alleviating Mitochondrial Dysfunction and Oxidative Stress-Induced Apoptosis in rat model

    A. Kumar (Allahabad, India)

    Objective: The objective of this study was to evaluate the neuroprotective efficacy of Betulin in MPTP-induced mice models of Parkinson's disease (PD), focusing on its…
  • 2024 International Congress

    Beta peaks as predictor for DBS outcome in Parkinson’s disease

    V. Molinari, M. Sure, E. Florin, C. Hartmann, A. Schnitzler (Düsseldorf, Germany)

    Objective: Determining the relevance of subthalamic (STN) beta peaks in Parkinson's disease (PD) patients with deep brain stimulation (DBS) in relation to the best possible…
  • 2024 International Congress

    Adherence and Persistence Among Patients with Parkinson’s Disease Initiating Istradefylline: 12-Month Follow-Up from US Real-World Data

    R. Joseph, J. Qian, H. Cummings, Y. Chen, S. Tewari, M. Soileau (Columbus, USA)

    Objective: To evaluate 12-month adherence and persistence and identify factors associated with persistence among Parkinson’s disease (PD) patients initiating istradefylline, the first non-dopaminergic adjunct targeting…
  • 2024 International Congress

    Bioreactor-produced iPSCs-derived Dopaminergic Neuron-containing Neural Microtissues Innervate and Restore Motor Function in a Dose-dependent Manner in a Parkinson Rat Model

    N. Prudon, L. Cordero-Espinoza, M. Abarkan, B. Gurchenkov, C. Morel, M. Lepleux, V. de Luca, N. Pujol, L. Milvoy, P. Morand, F. Moncaubeig, H. Wurtz, L. Poinçot, M. Demarco, A. Jonckeau, J. Plétenka, E. Luquet, K. Schmit, L. Piouceau, S. Guilbert, L. Manache-Alberici, M. Lanero, G. Dabee, T. Dufourd, J. Schroeder, K. Alessandri, E. Bezard, E. Faggiani, M. Feyeux (Bordeaux, France)

    Objective: To demonstrate the efficacy of a ready-to-graft 3D neural microtissue product – manufactured at large scale – as a therapeutically viable option to treat Parkinson’s…
  • 2024 International Congress

    Clinical Response and Reduction in Medication Use After Deep Brain Stimulation Surgery in a Cohort of Parkinson’s Disease Patients in Colombia

    T. Lopez Gonzalez, S. Poveda, M. Fonseca, P. Arango, O. Rojas, G. Monsalve, JC. Diez, J. Lobato, O. Bernal Pacheco (Bogotá, Colombia)

    Objective: The objective is to investigate the clinical outcomes and subsequent use of medications in a group of Colombian Patients with DBS Surgery. Background: Parkinson's…
  • 2024 International Congress

    A case of malignant Deep Brain Stimulation Withdrawal Syndrome treated with Opicapone

    D. Brogle, L. Zünd-Hofer, F. Brugger, G. Kägi (Sankt Gallen, Switzerland)

    Objective: We present a case of a patient with Parkinson's disease who developed "malignant Deep Brain Stimulation (DBS) Withdrawal Syndrome" following the removal of the…
  • 2024 International Congress

    Exploring the Therapeutic Target for Lewy Body Disease using gba1 Knock-out Medaka

    E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, H. Yamakado, R. Takahashi (kyoto, Japan)

    Objective: This study was performed to explore the therapeutic target for Lewy body disease. Background: Lewy body disease (LBD), including Parkinson's disease and diffuse Lewy…
  • 2024 International Congress

    Sphingomyelinase Activity in Patients with Sporadic Parkinson’s Disease

    A. Rekik, A. Mili, S. Naija, E. Jarrar, K. Jemai, A. Hassine, S. Ben Amor, J. Ben Abdallah (Sousse, Tunisia)

    Objective: To measure the sphingomyelinase (ASMase) activity in sporadic PD patients and matched healthy controls and identify any clinical or biological correlation with disease’s severity.To…
  • 2024 International Congress

    Machine Learning Model Comparison for Freezing of Gait Prediction in Advanced Parkinson’s Disease Patients

    J. Watts, A. Khojandi, R. Ramdhani (Knoxville, USA)

    Objective: This study compares the performance of machine learning classification models in predicting freezing of gait (FoG) from instrumented stand-and-walk trials in advanced Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 293
  • 294
  • 295
  • 296
  • 297
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley